Ferring Pharmaceuticals

Euflexxa

Manufacturer:

Ferring Pharmaceuticals

Euflexxa HCPCS:

J7323

HCPCS Code Descriptor:

Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose

Category:

J Code

Euflexxa NDCs:

55566-4100-01

Primary Type:

Orthopedic

Generic/Specialty Status:

Single-Source

Route of Administration:

Injection

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

55566-4100-01

About Euflexxa:

Euflexxa is an Orthopedic drug manufactured by Ferring Pharmaceuticals and administered via the Injection route of administration. The J Code: J7323 is aligned to the drug Euflexxa.

Euflexxa is an injection used to treat knee pain and joint inflammation caused by osteoarthritis. Also known as Sodium Hyaluronate, Euflexxa contains hyaluronate, mimicking a substance that naturally occurs in the joints. Euflexxa is often prescribed to patients whose pain has been resistant to other forms of treatment, such as over the counter pain relievers, exercise, and physical therapy. Euflexxa can act both as a lubricant and a shock absorber in the knee. This helps the joint move more easily, thereby lessening pain and discomfort.

ACCESS PRICING AND MORE BY REGISTERING

J7323 Added Date:

January 1, 2008

J7323 Effective Date:

January 1, 2008

J7323 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Euflexxa billing and coding information.
Our team did not identify a source for Euflexxa patient assistance information. Please reach out to our team if you feel that this is a mistake.
Euflexxa prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for Euflexxa. Please check back in a few weeks.